Deepening our understanding of the molecular mechanisms underlying the HMGCR-TNF-α axis in regulating ferroptosis, in conjunction with tumor type, TNF-α signaling intensity, and HMGCR expression levels, may provide novel therapeutic targets for cancer treatment. This evidence concerns the gene TNF and neoplasm.